Treponema Pallidum: Structure, Genetics, Pathogenicity, and Diagnosis

Treponema pallidum subspecies pallidum, the bacterium responsible for syphilis, is one of the most elusive human pathogens ever studied. Its unusual spiral shape, bare outer membrane, and inability to survive outside a host have frustrated researchers for more than a century. What makes this organism so difficult to pin down is also what makes it so effective at causing disease: it slips past the immune system, burrows through tissues, spreads to nearly every organ, and can persist in the body for decades. Understanding its structure, genetic quirks, methods of invasion, and the diagnostic tools used to catch it reveals why syphilis remains a serious global health problem even in an era of advanced medicine.

An Outer Membrane Built for Stealth

Most bacteria that infect humans display a dense array of proteins and molecules on their surfaces, essentially waving flags that the immune system learns to recognize. T. pallidum does the opposite. Its outer membrane lacks lipopolysaccharide, the molecule that triggers intense inflammation in infections caused by other gram-negative bacteria, and carries an extremely low density of surface-exposed proteins.¹ This sparse surface has earned T. pallidum the label “stealth pathogen,” a term used to describe its poorly antigenic and non-inflammatory exterior.²

The outer membrane acts as a physical barrier to antibody binding. Most of the bacterium’s immunogenic lipoproteins sit underneath, hidden in the periplasmic space between the outer and inner membranes rather than exposed on the surface.³ The result is that the immune system has very few targets to latch onto. Antibodies may be circulating in the bloodstream, but the organism presents almost nothing for them to bind. This is a major reason why syphilis can persist through multiple stages of disease, sometimes over years, despite a vigorous host immune response.

Corkscrew Motility

T. pallidum is a spirochete, meaning it has a distinctive helical shape and moves with a corkscrew-like rotation. Unlike most bacteria, whose flagella extend outward into the surrounding fluid, spirochete flagella are tucked inside the periplasmic space, sandwiched between the inner and outer membranes. These periplasmic flagella wrap around the cell body in a supercoiled configuration and drive a form of locomotion that is unusually effective at boring through thick tissue, including the gel-like extracellular matrix that surrounds human cells.⁴

Cryo-electron tomography studies have revealed how the flagellar motors and filaments are specially adapted to rotate within the tight confines of the periplasmic space.⁵ Recent structural work on a closely related Treponema species showed that the flagellar filament has an asymmetric design. A core made of the FlaB protein is surrounded by a sheath, with the major sheath protein FlaA forming the bulk and four minor sheath proteins assembling along the concave side to accommodate the filament’s inherent curvature. Disrupting this asymmetric arrangement compromises force transmission and impairs motility.⁴ This architecture is not just an evolutionary curiosity. The ability to bore efficiently through tissue is central to how T. pallidum spreads from an initial sore to the bloodstream and, eventually, to distant organs.

A Minimalist Genome and Borrowed Metabolism

T. pallidum has one of the smallest genomes of any known pathogen. It encodes only about a thousand genes, reflecting a lifestyle of extreme dependence on its human host. Over evolutionary time, the organism has shed the genetic instructions for making many essential molecules, including most amino acids and cofactors, relying instead on scavenging them from host tissues. It also lacks a conventional electron transport chain, the molecular machinery that most bacteria use to generate energy aerobically. Metabolic modeling has identified the enzyme glycerol-3-phosphate dehydrogenase as an alternative way the organism maintains its internal chemical balance in the absence of that standard energy pathway.⁶

Despite its small size, the genome is not static. Pan-genome analysis of multiple T. pallidum strains has revealed differences in genomic plasticity among the subspecies that cause syphilis, yaws, and bejel. The subspecies differ in the presence or absence of pathogenicity islands and genomic islands, segments of DNA often associated with virulence and adaptation.⁷ Studies comparing genes under positive selection across the syphilis-causing subspecies (TPA) and the yaws-causing subspecies (TPE) found about 22 positively selected genes, with different sets under adaptive pressure in each, suggesting that despite their close genetic relatedness, the subspecies are evolving along distinct paths shaped by different host environments and modes of transmission.⁸

How the Spirochete Invades and Disseminates

Getting from an initial skin or mucosal lesion into the bloodstream requires T. pallidum to latch onto host tissue and then cross the endothelial barriers that line blood vessels. The organism accomplishes this with a toolkit of adhesin proteins that bind to components of the extracellular matrix. Two treponemal proteins, Tp0155 and Tp0483, have been shown to bind specifically to fibronectin, a key structural protein in connective tissue, and to mediate attachment to host cells.⁹

Another adhesin, Tp0751 (also called pallilysin), is a particularly versatile player. It binds not only to fibronectin but also to laminin, fibrinogen, and collagen, the major structural proteins of the basement membrane and surrounding tissue.¹⁰ Tp0751 has also been shown to disrupt VE-cadherin, the main protein holding endothelial cells together at junctions, suggesting a role in prying apart the lining of blood vessels.¹¹

Crossing the endothelial barrier itself appears to involve at least two routes. Experiments show that T. pallidum can traverse endothelial layers without causing a measurable drop in barrier integrity, and that this process is reduced when cholesterol-mediated uptake is blocked, pointing to an active cellular transport mechanism. At the same time, the organism localizes to and disrupts intercellular junctions, suggesting it may also squeeze between cells.¹¹ More recent work has identified additional mechanisms: live T. pallidum can trigger signaling pathways in endothelial cells that destabilize the surrounding fibronectin matrix, further easing its passage through tissue.¹² And the treponemal lipoprotein Tp0768 has been found to increase endothelial permeability by downregulating tight junction proteins through a metabolic-epigenetic pathway, representing yet another strategy for breaching barriers.¹³

Antigenic Variation and Long-Term Immune Evasion

The sparse outer membrane described earlier gives T. pallidum an initial advantage over the immune system, but that alone does not explain how the bacterium persists for years. The key to long-term survival lies in a system of antigenic variation centered on a surface protein called TprK. This protein has seven discrete variable regions where its amino acid sequence can change during infection. New sequences are generated through a process resembling gene conversion, in which the bacterium copies segments from silent “donor” sequences elsewhere in its genome and splices them into the active TprK gene.¹⁴

This reshuffling creates a moving target. The host’s immune system mounts antibody responses against the TprK variants it encounters first, but by the time those antibodies are effective, new variants have already arisen. In the rabbit model of syphilis, secondary lesions were about three times more likely than primary lesions to contain predominantly TprK-variant bacteria, and the immune system showed significantly stronger antibody responses against the original TprK sequences than against the new variants found in secondary lesions.¹⁵ When researchers genetically impaired the TprK variation system by eliminating the donor cassettes, the mutant bacteria generated drastically fewer new variants and were significantly weakened in the rabbit model compared to wild-type bacteria.¹⁶ This confirms that TprK variation is not just a side effect of infection but a critical driver of the bacterium’s ability to survive and cause progressive disease.

What the Disease Looks Like in Tissue

The clinical stages of syphilis (primary, secondary, latent, and tertiary) reflect the interplay between spirochetal invasion and host immune responses. Tissue biopsies from syphilitic lesions consistently show dense infiltration by immune cells called lymphocytes and plasma cells, often with inflammation clustered around blood vessels and damage to the overlying tissue surface.¹⁷ This pattern appears across affected sites, from genital chancres to oral lesions to skin rashes.

In later stages, the consequences become more severe. T. pallidum can penetrate the blood-brain barrier and infiltrate the central nervous system, leading to neurosyphilis. The bacterium’s invasive properties and the immune response it provokes both contribute to neural damage, and host factors along with specific T. pallidum genotypes appear to influence susceptibility to neurological involvement.¹⁸ Cardiovascular syphilis, another late manifestation, involves inflammation of the tiny blood vessels that nourish the aortic wall (the vasa vasorum), leading to weakening and potential aneurysm formation. Congenital syphilis, caused by transplacental transmission, produces characteristic placental changes: enlarged hypercellular villi, proliferative fetal vascular changes, and villitis.¹⁹ Stillborn infants with congenital syphilis are far more likely to show a condition called erythroblastosis in placental tissue.²⁰

Diagnosing Syphilis

Syphilis diagnosis relies on a combination of direct detection methods and blood-based antibody tests. No single test is perfect for every stage, which is why clinical context matters so much.

Direct detection, when a lesion is present, has traditionally meant dark-field microscopy: placing fluid from a sore under a specialized microscope to look for the characteristic spiraling organisms. This method works but is increasingly rare in clinical settings because it requires specialized equipment and trained eyes. PCR-based tests that detect T. pallidum DNA have largely taken over as the most reliable direct detection method. A real-time PCR targeting the polA gene, for example, achieved sensitivities and specificities between 94 and 100 percent in validation studies.²¹ PCR can also be used for strain typing and testing for antibiotic resistance genes, adding diagnostic value beyond just confirming infection.²² One limitation is that PCR works well in primary syphilis, where there is a lesion to swab, but adds little to the diagnosis of secondary syphilis, where the bacterium has already spread systemically.²³

For screening and staging, blood tests are the mainstay. These come in two categories: nontreponemal tests (like the VDRL and RPR) and treponemal tests (like the FTA-Abs, TPHA, and automated immunoassays). Nontreponemal tests detect antibodies against lipid material released from damaged cells and from the bacterium itself. They are inexpensive and useful for tracking disease activity because their titers rise and fall with treatment. However, they are prone to false positives, caused by conditions ranging from autoimmune diseases to infections like infectious mononucleosis, and to a phenomenon called the prozone reaction, in which very high antibody levels paradoxically produce a negative result.²⁴ Among false-positive cases, those driven by Epstein-Barr virus-associated mononucleosis tend to produce unusually high titers, which can make them harder to distinguish from true syphilis.²⁵

Treponemal tests detect antibodies specifically targeting T. pallidum proteins. They typically remain positive for life, even after successful treatment, so they confirm exposure but cannot distinguish current from past infection.

Traditional Versus Reverse Screening

The order in which these tests are performed matters more than many people realize. The traditional algorithm starts with a nontreponemal test (RPR or VDRL) and confirms positive results with a treponemal test. The reverse algorithm flips this, starting with an automated treponemal immunoassay and following up positives with a nontreponemal test. Both approaches have trade-offs. In a comparison from an Indian national referral laboratory, the traditional algorithm missed about a third of seropositive cases that the reverse algorithm caught, largely because nontreponemal tests can be negative in early primary and late latent syphilis when antibody titers are low.²⁶ A Korean study found a similar pattern: traditional screening detected only about 1 percent of specimens as reactive compared with roughly 7 percent by reverse screening, with dozens of cases confirmed by a second treponemal test that the traditional path never flagged.²⁷

The reverse algorithm is not without drawbacks. In a low-prevalence population, it produced more false-reactive results on the initial screen than the traditional algorithm, though it also caught possible latent infections the traditional path missed.²⁸ The practical implication is that many high-volume laboratories have shifted to the reverse algorithm because automated treponemal assays are easier to run at scale, but clinicians interpreting the results need to understand that a positive treponemal screen with a negative RPR does not automatically mean active disease. It could represent treated past infection, very early syphilis before nontreponemal antibodies have appeared, or a false positive requiring a confirmatory second treponemal test.

Why Penicillin Still Works and Macrolide Resistance Does Not Help

T. pallidum has a cell wall containing peptidoglycan, the mesh-like structure that penicillin disrupts. The organism carries several penicillin-binding proteins, with the 94-kDa and 58-kDa forms showing the highest binding affinity. One of its most abundant proteins, the 47-kDa lipoprotein Tpp47, is itself a penicillin-binding protein with enzymatic activity involved in cell-wall maintenance.²⁹ An interesting quirk is that even at high concentrations, penicillin only immobilizes about 40 percent of bacteria during prolonged lab incubation, likely because T. pallidum divides very slowly and penicillin only kills actively dividing cells.³⁰ Despite over 80 years of use, no penicillin resistance has been documented in T. pallidum, making it one of the few remaining pathogens for which the original antibiotic is still the first-line treatment.

The same cannot be said for macrolide antibiotics like azithromycin, which are sometimes used as alternatives in penicillin-allergic patients. Resistance to macrolides in T. pallidum is driven by point mutations at positions A2058G or A2059G in both copies of the 23S ribosomal RNA gene.³¹ Clinical strains carrying either mutation showed functional resistance to azithromycin treatment in rabbit models, meaning the bacteria remained infectious in treated animals despite antibiotic exposure.³² In many parts of the world, macrolide-resistant strains now make up a substantial proportion of circulating T. pallidum, which is why azithromycin is no longer recommended as a reliable standalone treatment.

The Breakthrough in Culturing T. pallidum

For over a century, one of the biggest obstacles to syphilis research was the inability to grow T. pallidum in the laboratory. The organism’s extreme host dependence meant that researchers had to maintain it by infecting rabbits and harvesting bacteria from their tissues, a cumbersome, expensive, and ethically fraught process that severely limited experimental options. In 2018, researchers achieved a long-sought breakthrough: continuous in vitro culture using a system of co-culture with rabbit epithelial cells in a specially formulated medium under low-oxygen conditions.³³

The system has since been maintained for over three years with multiple strains, with bacteria passaged weekly and retaining full motility and infectivity.³⁴ Cultured T. pallidum divides roughly every 33 to 45 hours, similar to its estimated doubling time during natural human infection, and requires a low-oxygen environment of about 1.5 percent at 34°C.³⁵ While the culture system still demands rabbit epithelial cells as a co-culture partner and remains technically challenging, it has already opened doors to genetic manipulation experiments, drug-susceptibility testing, and structural studies that were previously impossible.

HIV and Syphilis Together

HIV and T. pallidum frequently co-occur because they share transmission routes, and each infection worsens the other. Syphilis causes mucosal ulcers that create entry points for HIV, while HIV’s suppression of the immune system may alter the clinical presentation and course of syphilis. In people living with both infections, syphilis co-infection has been associated with higher rates of failure to suppress HIV viral load on antiretroviral therapy, with an odds ratio of about 1.3, and slower recovery of immune cell counts compared to HIV infection alone.³⁶ Co-infection also raises the likelihood of serious complications like neurosyphilis and can complicate serological diagnosis, since immune suppression may blunt the antibody responses that syphilis tests rely on.³⁷

Prospects for a Syphilis Vaccine

A vaccine against syphilis has been a goal for decades, but the same features that make T. pallidum a stealth pathogen also make vaccine development exceptionally difficult. The sparse outer membrane offers few surface targets, genetic manipulation of the organism has been extremely limited until recently, and the complex antigenic variation system means that targeting a single surface protein may not be enough.

The most promising lead so far involves the Tp0751 adhesin described earlier. In the rabbit model, immunization with the lipocalin domain of Tp0751 significantly reduced treponemal dissemination within the host, the critical step that leads to secondary lesions, congenital transmission, and late complications.³⁸ Multi-epitope vaccine designs that combine immunogenic fragments from several different adhesin proteins are also being explored computationally, with the idea that targeting multiple proteins simultaneously could provoke a broader immune response and reduce the chances that the bacterium slips past through variation of any single target.³⁹ These approaches remain in preclinical stages, but the combination of the new in vitro culture system and improving genetic tools has made the prospect more realistic than at any previous point in the long history of syphilis research.